Nordic Trial Alliance

The purpose of the Nordic Trial Alliance (NTA) is to make it easier to carry out clinical research in the Nordic countries.

Clinical Trials illustration

The illustration shows the progression of a clinical trial.
Clinical trials are designed in several different ways. The number of patients involved in a trial for cancer treatment, for instance, will often be lower than other types of trials.


The overall aim of NTA is to enhance Nordic cooperation on clinical multi-centre trials. 
Increased Nordic cooperation on clinical research will lead to a rise in the number of joint clinical trials and thus boost the attractiveness of the Nordic countries as partners in research. Such activities will also promote knowledge transfer as well as increased efficiency and research output.

The Nordic Trial Alliance is based on established national networks for clinical research, and will lay the foundation for increased collaboration between national and Nordic stakeholders.

The Nordic Trial Alliance (NTA) is a three-year pilot project funded by the Nordic Council of Ministers and NordForsk.

The Nordic Trial Alliance (NTA) is a three-year pilot project running from 2013 to 2015, funded by the Nordic Council of Ministers and NordForsk.